Home / Inspections / 1017014

FDA Inspection 1017014 — Somerset Therapeutics Private Limited

Somerset Therapeutics Private Limited — FEI 3003821988

The FDA completed an inspection of Somerset Therapeutics Private Limited on April 24, 2017 in Bengaluru. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 24, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bengaluru (India)

Facility

Other inspections at this facility

  • 1261727 (OAI Fri Feb 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1226714 (VAI Fri Oct 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1166834 (OAI Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1118121 (OAI Wed Feb 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1097269 (VAI Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources